Embecta Corp. (EMBC)
5.24
-0.31
(-5.59%)
USD |
NASDAQ |
Sep 09, 12:16
Embecta Price : 5.24 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 5.71 | 5.76 | 5.475 | 5.55 | 1.362M |
| Sep 04, 2026 | 5.63 | 5.91 | 5.60 | 5.80 | 1.001M |
| Sep 03, 2026 | 5.70 | 5.77 | 5.505 | 5.69 | 1.160M |
| Sep 02, 2026 | 5.27 | 5.695 | 5.27 | 5.69 | 1.302M |
| Sep 01, 2026 | 5.07 | 5.315 | 5.06 | 5.25 | 2.090M |
| Aug 31, 2026 | 5.00 | 5.235 | 4.92 | 5.14 | 2.766M |
| Aug 28, 2026 | 5.03 | 5.179 | 4.99 | 5.05 | 1.473M |
| Aug 27, 2026 | 4.90 | 5.00 | 4.80 | 4.97 | 952638.0 |
| Aug 26, 2026 | 4.98 | 5.015 | 4.89 | 4.96 | 817063.0 |
| Aug 25, 2026 | 4.99 | 5.04 | 4.875 | 5.03 | 1.288M |
| Aug 24, 2026 | 5.195 | 5.275 | 4.95 | 4.99 | 991822.0 |
| Aug 21, 2026 | 5.43 | 5.47 | 5.12 | 5.23 | 1.127M |
| Aug 20, 2026 | 5.32 | 5.625 | 5.32 | 5.47 | 1.624M |
| Aug 19, 2026 | 5.10 | 5.43 | 5.10 | 5.42 | 1.264M |
| Aug 18, 2026 | 5.13 | 5.38 | 5.065 | 5.10 | 1.109M |
| Aug 17, 2026 | 5.02 | 5.26 | 4.975 | 5.13 | 1.571M |
| Aug 14, 2026 | 5.16 | 5.21 | 4.985 | 5.10 | 1.540M |
| Aug 13, 2026 | 4.72 | 5.22 | 4.72 | 5.11 | 2.619M |
| Aug 12, 2026 | 4.99 | 5.000 | 4.63 | 4.75 | 1.651M |
| Aug 11, 2026 | 4.92 | 5.14 | 4.845 | 4.88 | 2.464M |
| Aug 10, 2026 | 4.44 | 5.01 | 4.20 | 4.99 | 4.012M |
| Aug 07, 2026 | 4.14 | 4.69 | 3.96 | 4.42 | 5.588M |
| Aug 06, 2026 | 3.52 | 3.619 | 3.47 | 3.50 | 1.324M |
| Aug 05, 2026 | 3.81 | 3.81 | 3.51 | 3.57 | 1.098M |
| Aug 04, 2026 | 3.70 | 3.85 | 3.70 | 3.82 | 1.048M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Artivion, Inc. | 25.42 |
| Abbott Laboratories | 105.81 |
| AngioDynamics, Inc. | 15.35 |
| Alphatec Holdings, Inc. | 9.29 |
| AtriCure, Inc. | 53.41 |
Price Related Metrics
| PE Ratio | 3.531 |
| PS Ratio | 0.3034 |
| PEG Ratio | 0.9459 |
| Price to Free Cash Flow | 1.878 |
| Earnings Yield | 28.32% |
| Market Cap | 296.90M |
| PEGY Ratio | 0.3718 |
| Operating PE Ratio | 1.150 |
| Normalized PE Ratio | 2.449 |